Literature DB >> 12514411

The clinical spectrum of hepatitis C virus in HIV coinfection.

Richard K Sterling1, Melissa J Contos, Arun J Sanyal, Velimir A Luketic, R Todd Stravitz, Mary S Wilson, A Scott Mills, Mitchell L Shiffman.   

Abstract

The biochemical, virologic, and histologic spectrum of hepatitis C virus (HCV) in 66 consecutive patients with HIV-HCV coinfection and 119 HCV controls was compared: 86% of coinfected patients had CD4 counts >200 cells/mm3, 51% had a normal alanine aminotransferase (ALT) value, the mean HCV RNA titer was 5.7 log IU/mL, 92% of coinfected patients were of genotype 1, and the mean histologic activity index was 6.86 with advanced fibrosis in 32% of patients. The biochemical, virologic, and histologic findings of HCV in coinfected patients were similar to those observed in HCV controls. For both groups of patients, no clinical, biochemical, or virologic factors could reliably identify patients with advanced fibrosis or cirrhosis, underscoring the importance of liver biopsy in the evaluation of these patients. The spectrum of liver disease in coinfection includes a significant proportion of patients with normal ALT values, and excluding these patients from previous studies has led to an overestimation of HCV disease severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514411     DOI: 10.1097/00126334-200301010-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.

Authors:  Richard K Sterling; Jacob A Wegelin; Paula G Smith; R Todd Stravitz; Velimir A Luketic; Michael Fuchs; Puneet Puri; Mitchell L Shiffman; Melissa A Contos; A Scott Mills; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

2.  HIV coinfection with hepatitis C and hepatitis B.

Authors:  Jenny O Smith; Richard K Sterling
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

Review 4.  Hepatitis C and HIV.

Authors:  Jenny O Smith; Richard K Sterling
Journal:  Curr Gastroenterol Rep       Date:  2007-03

5.  Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Authors:  Amy G Shah; Paula G Smith; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2011-04-28       Impact factor: 3.199

6.  Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.

Authors:  G F de Larrañaga; S D A Perés Wingeyer; L M Puga; B S Alonso; J A Benetucci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

7.  The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Authors:  Karen H Seal; Alex Monto; Lorna Dove; Hui Shen; Eric Vittinghoff; Daniel Tracy; Erica Miller; Eva Lau; Teresa L Wright
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.